International travelers to the U.S. will no longer require COVID-19 Vaccination

On May 1, 2023, the Biden Administration announced the end of the COVID-19 vaccine requirement for all international air travelers effective at the end of day on May 11, 2023. The announcement includes a broader ending of vaccine requirements in connection with the official end of the federal COVID-19 public health emergency.

Beginning on January 26, 2021, all international air travelers, including U.S. citizens, were required to present a negative COVID-19 test before traveling to the United States. The Biden Administration cites the significant decrease of COVID-19 related deaths and hospitalizations resulting from the Administration’s COVID-19 response as the reason for eliminating the COVID-19 vaccine requirement for all international air travelers.

We will continue to monitor the implementation of this and other new requirements, keep abreast of any additions, and notify you of any material changes.

Please contact any member of the Dentons Immigration team if you have any questions.

Subscribe and stay updated

Receive our latest blog posts by email.

Stay in Touch

COVID-19, United States

About Adam Teets

Adam is an associate in the Immigration group in the Pittsburgh, PA office. Adam’s practice focuses on employment-based immigration, including temporary and permanent visas and family-based permanent residence applications. Adam has a special interest in cases involving all types of non-immigrant and immigrant visas; labor certification (PERM) and EB-1 visas; options and issues concerning health care workers/physicians, including 212(e) waivers of the two-year home residency requirement.

About Ana Maria Mieles

Ana María is a Shareholder in the Immigration and International Business Groups. She counsels domestic and multinational corporations on a wide array of investment and employment immigration matters, federal compliance issues, global/outbound immigration, and federal litigation. Ana María represents employers and investors from various industries, including chemicals, pharmaceuticals, medical/healthcare, public and private education, financial services, engineering, technology, nuclear, and steel.